MLXIPL and hepatocellular carcinoma: The clinical relevance of ChREBP expression levels during human liver carcinogenesis was first evaluated by assessing the relationship between its expression and patient’s clinicopathological records in two independent HCC cohorts, namely LIHC and LICA-FR, for which clinical data were available (Supplementary Tables 1 and 2 and Supplementary Data 1 and 2).